Publication Name	World Journal of Gastroenterology
Manuscript ID	63719
Country	Italy

Received	2021-02-01 12:32
Peer-Review Started	2021-02-01 12:36
To Make the First Decision
Return for Revision	2021-02-27 05:57
Revised	2021-03-13 13:31
Second Decision	2021-03-19 11:21
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-03-19 14:44
Articles in Press	2021-03-19 14:44
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-03-23 22:10
Typeset the Manuscript	2021-03-30 14:23
Publish the Manuscript Online	2021-04-09 09:07

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	COVID-19 and gastrointestinal tract: Source of infection or merely target of the inflammatory process following SARS-CoV-2 infection?
Manuscript Source	Invited Manuscript
All Author List	Jacopo Troisi, Giorgia Venutolo, Meritxell Pujolassos Tanyà, Matteo Delli Carri, Annamaria Landolfi and Alessio Fasano
Funding Agency and Grant Number
Corresponding Author	Jacopo Troisi, MBBS, MSc, Additional Professor, Professor, Metabolomics Section, Theoreo srl - Spin-off Company of the University of Salerno, Via degli Ulivi, 3, Montecorvino Pugliano 84090, SA, Italy. troisi@theoreosrl.com
Key Words	COVID-19; SARS-CoV-2; Gastrointestinal symptoms; Gut microbiome; Dysbiosis; Zonulin; Fecal-oral transmission
Core Tip	Coronavirus disease 2019 patients may suffer from gastrointestinal symptoms, which have been associated to gastrointestinal dysbiosis. Even though the exact role of gut microbiome perturbation (as a cause or a consequence of the disease) is still to be elucidated, pharmacological interventions aimed at containing intestinal permeability may be of support for coronavirus disease 2019 patients.
Publish Date	2021-04-09 09:07
Citation	Troisi J, Venutolo G, Pujolassos Tanyà M, Delli Carri M, Landolfi A, Fasano A. COVID-19 and gastrointestinal tract: Source of infection or merely target of the inflammatory process following SARS-CoV-2 infection? World J Gastroenterol 2021; 27(14): 1406-1418
URL	https://www.wjgnet.com/1007-9327/full/v27/i14/1406.htm
DOI	https://dx.doi.org/10.3748/wjg.v27.i14.1406

Full Article (PDF)	WJG-27-1406.pdf
Full Article (Word)	WJG-27-1406.docx
Manuscript File	63719-Review-FilipodiaCL.docx
Answering Reviewers	63719-Answering reviewers.pdf
Audio Core Tip	63719-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	63719-Conflict-of-interest statement.pdf
Copyright License Agreement	63719-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	63719-Language certificate.pdf
Peer-review Report	63719-Peer-review(s).pdf
Scientific Misconduct Check	63719-Scientific misconduct check.pdf
Scientific Editor Work List	63719-Scientific editor work list.pdf
CrossCheck Report	63719-CrossCheck report.pdf